Management of concomitant risk

Megan E. Miller*, Sarah M. Nielsen, Swati A. Kulkarni

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Breast cancer risk has been well-characterized for a number of genetic syndromes including carriers of BRCA1/BRCA2, TP53, and PTEN. This chapter will focus primarily on the risk of developing other malignancies in those individuals or family members with a genetic predisposition to breast cancer. Screening protocols and risk reduction strategies will also be reviewed for individual malignancies where appropriate (Table 10.1).

Original languageEnglish (US)
Title of host publicationManagement of the Patient at High Risk for Breast Cancer
PublisherSpringer New York
Pages141-154
Number of pages14
ISBN (Electronic)9781461458913
ISBN (Print)1461458900, 9781461458906
DOIs
StatePublished - Nov 1 2013

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Management of concomitant risk'. Together they form a unique fingerprint.

  • Cite this

    Miller, M. E., Nielsen, S. M., & Kulkarni, S. A. (2013). Management of concomitant risk. In Management of the Patient at High Risk for Breast Cancer (pp. 141-154). Springer New York. https://doi.org/10.1007/978-1-4614-5891-3_10